Source: Frontiers in Pharmacology. Unidade: ICB
Subjects: PARASITOLOGIA, MALÁRIA, PLASMODIUM, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Marilia Nunes do Nascimento et al. QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities. Frontiers in Pharmacology, v. 9, n. 146, p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00146. Acesso em: 28 ago. 2024.APA
Lima, M. N. do N., Melo-Filho, C. C., Cassiano, G. C., Neves, B. J., Alves, V. M., Braga, R. C., et al. (2018). QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities. Frontiers in Pharmacology, 9( 146), 1-13. doi:10.3389/fphar.2018.00146NLM
Lima MN do N, Melo-Filho CC, Cassiano GC, Neves BJ, Alves VM, Braga RC, Cravo PVL, Muratov E, Calit J, Bargieri DY, Costa FTM, Andrade CH. QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities [Internet]. Frontiers in Pharmacology. 2018 ; 9( 146): 1-13.[citado 2024 ago. 28 ] Available from: https://doi.org/10.3389/fphar.2018.00146Vancouver
Lima MN do N, Melo-Filho CC, Cassiano GC, Neves BJ, Alves VM, Braga RC, Cravo PVL, Muratov E, Calit J, Bargieri DY, Costa FTM, Andrade CH. QSAR-driven design and discovery of novel compounds with antiplasmodial and transmission blocking activities [Internet]. Frontiers in Pharmacology. 2018 ; 9( 146): 1-13.[citado 2024 ago. 28 ] Available from: https://doi.org/10.3389/fphar.2018.00146